Search company, investor...

American Esoteric Laboratories

ael.com

Founded Year

2003

Stage

Acquired | Acquired

Total Raised

$70M

Valuation

$0000 

About American Esoteric Laboratories

American Esoteric Laboratories, Inc. (AEL) aims to provide hospitals with turn-around time, informatics, and personalized customer service in the esoteric and other clinical reference laboratory services sector.

Headquarters Location

9200 Wall Street

Austin, Texas, 78754,

United States

512-339-1275

Missing: American Esoteric Laboratories's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: American Esoteric Laboratories's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

American Esoteric Laboratories Frequently Asked Questions (FAQ)

  • When was American Esoteric Laboratories founded?

    American Esoteric Laboratories was founded in 2003.

  • Where is American Esoteric Laboratories's headquarters?

    American Esoteric Laboratories's headquarters is located at 9200 Wall Street, Austin.

  • What is American Esoteric Laboratories's latest funding round?

    American Esoteric Laboratories's latest funding round is Acquired.

  • How much did American Esoteric Laboratories raise?

    American Esoteric Laboratories raised a total of $70M.

  • Who are the investors of American Esoteric Laboratories?

    Investors of American Esoteric Laboratories include Sonic Healthcare, Oak Investment Partners and ABS Capital Partners.

  • Who are American Esoteric Laboratories's competitors?

    Competitors of American Esoteric Laboratories include Genoptix, Critical Diagnostics, Ameritox, American Pathology Partners, IBT Laboratories and 12 more.

Compare American Esoteric Laboratories to Competitors

C
CynerGene

CynerGene aims to provide laboratory services for researchers, pharmaceuticals and biotech companies. The firm aims to generate high quality data using the company's QC-centric pipeline. CynerGene is a GLP compliant lab currently pursuing CLIA certification.

D
Dolphin Imaging Systems

Dolphin aims to provide quality imaging, diagnostic and management solutions for dental-specialty practices and institutions.

O
Oxensis

Oxensis operates a laboratory. It is a a Rutherford Appleton laboratory.

P
Progenix Research

Progenix Research is an independent contract research organisation offering toxicology services to the world-wide pharmaceutical, biotechnology, agrochemical and industrial chemical industries. It is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. The company's European headquarters are based in Malvern, England, and it also has a histopathology laboratory in Edinburgh, Scotland. A high quality, yet cost-efficient service for toxicology and associated studies will be offered, including studies on pharmaceuticals, biotechnology products, medical devices, food additives, agrochemicals, biocides, and speciality chemicals.

L
Laboratory Partners

Laboratory Partners is a provider of outsourced diagnostic laboratory services.

SAFC Logo
SAFC

SAFC, Inc. is an FDA-registered, good manufacturing practices, organic synthetic laboratory engaged in the production of experimental pharmaceuticals and pharmaceutical products.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.